Safeguarding public health. The British Pharmacopoeia. M Vallender Acting Group Manager, BP & Laboratory Services
|
|
|
- Tyrone Wells
- 7 years ago
- Views:
Transcription
1 The M Vallender Acting Group Manager, BP & Laboratory Services
2 OUTLINE Introduction National Activity European and International Activity Future Slide 2
3 INTRODUCTION Medicines and Healthcare products Regulatory Agency (MHRA) - UK Government Agency for ensuring medicines and medical devices work and are acceptably safe BP and Laboratory Services Group - BP incorporated into the MHRA Trading Fund in Part of Inspection, Enforcement and Standards Division of MHRA - 19 members (16.5 BP Lab Services) + 1 PA - Publications & Reference Materials (BP; BP (Vet); British Approved Names; Electronic Updates) - Website - Management of Laboratories (BP and MHRA) - Evaluation & development of BP monographs; BPCRS establishment - Forensic work ] - Support for Regulatory activity ] MHRA - Market surveillance ] Slide 3
4 BP and Laboratory Services Group (continued) Websites - Information about the BP News BPCRS Orders Forum for BPC Experts and Advisors Feedback to BP Secretariat - BP Online Sales of the BP Feedback to publisher and BP Secretariat Slide 4
5 Slide 5
6 LEGISLATION Medicines Act 1968 (Section 99) EC Directives 2001/83/EC (human medicines) 2004/27/EC (amending Directive 2001/83/EC) 2001/82/EC (veterinary medicines) 2004/28/EC (amending Directive 2001/82/EC) 2004/24/EC (traditional herbal medicinal products) 2001/83/EC (homoeopathic medicines) Slide 6
7 Regional Activity European Pharmacopoeia - National Pharmacopoeial Authority - Secretariat Support for the United Kingdom Delegation - UK Members of Groups of Experts and Working Parties European Medicines Agency - Names Review Group Invented names Slide 7
8 International Activity MHRA Policy World Health Organisation - Group of Experts on Nomenclature - International Nonproprietary Names - Memorandum of Understanding - Monograph Development Collaboration International harmonisation - Feedback to European Pharmacopoeia Chinese Pharmacopoeia - Memorandum of Understanding (MHRA & SFDA) - Collaboration Agreement between Chinese Pharmacopoeia & - TCMs & Mutually Agreed Projects Slide 8
9 Topics Covered in BP Medicinal substances (Human and Veterinary) Formulated Preparations General Monographs Specific Monographs Biological and Biotechnological Products (Blood Products, Vaccines etc) Radiopharmaceuticals Surgical Materials Herbal Medicines Homoeopathic Preparations Unlicensed Medicines Veterinary Medicines Methods of test Supplementary information Slide 9
10 Published Monographs Revision Programme - Medicines Act section 102 (1) - Targeted - Consequential - Responsive Slide 10
11 BP Publications Slide 11
12 Safeguarding public health Slide 12
13 BP & BP (Vet) Published August Effective 1 January new BP monographs - Integrates Ph Eur monographs - 3 In-year Electronic Updates - Available in Book and Electronic Formats Slide 13
14 Looking Ahead Annual BP and BP (Vet) Publication British Approved Names Supplements Increase in New Formulated Preparation Monographs (licensed and unlicensed) Supplementary Chapters for BP and BP (Vet) Red Tape Challenge European Pharmacopoeia (Expertise; Advice; Comments on drafts; Laboratory support; UK Government support) International Collaboration Stakeholder Co-operation (manufacturers; practitioners; pharmacies etc) Website Tailored Publications Feedback Slide 14
15 Future Strategy for World Pharmacopoeias Working together - Acknowledge roles of National Authority - Acknowledge regional roles - Acknowledge commercial activity Slide 15
16 Thank you Any Questions? Slide 16
1. Name of pharmacopoeia
1 1. Name of pharmacopoeia European Pharmacopoeia 36 Member states (Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece,
QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES
QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES Why are Pharmacopoeias so important in a globalised world? Pharmacopoeias have historically provided collections of medical recipes intended to ensure accurate
Importing pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
Memorandum of Understanding
Memorandum of Understanding between Department for Business, Innovation and Skills and United Kingdom Accreditation Service Page 1 of 13 Contents 1 Purpose... 3 2 Background... 3 3 Scope of activity...
Working with Professional Bodies
Working with Professional Bodies Our Schools School of Art and Design Business School School of Health and Education Award-winning students Real world research and collaboration Excellent research and
DRAFT FOR CONSULTATION. Homeopathic Medicines: Guidance on advertising
DRAFT FOR CONSULTATION Homeopathic Medicines: Guidance on advertising 1. Purpose of this Guideline This guidance has been developed by the Medicines and Healthcare products Regulatory Agency (MHRA) in
The Human Medicines Regulations 2012
STATUTORY INSTRUMENTS 2012 No. 1916 MEDICINES The Human Medicines Regulations 2012 Made - - - - 19th July 2012 Laid before Parliament 24th July 2012 Coming into force - - 14th August 2012 38.00 STATUTORY
HMPWG in the view of the NCA
EMEA Homeopathic Workshop Bundesinstitut für Arzneimittel London, 27.10.2006 HMPWG in the view of the NCA Objectives, Achievements, Roles and Responsibilities Werner Knöss Head of Division Complementary
Guide to Using. Public web application for searching and consulting the cosmetic ingredient and substance database. Last updated on 12 March 2009.
Guide to Using Public web application for searching and consulting the cosmetic ingredient and substance database Last updated on 12 March 2009. Contents Introduction 2 Overview...2 Disclaimer...3 Application
LICENCE FEES FOR MEDICINAL PRODUCTS FOR HUMAN USE ONLY PROPOSALS FOR APRIL 2002
Fax: 020 7273 0121 To all licence holders and representative associations Dear Sir/Madam Our Ref: MLX/277 15 November 2001 LICENCE FEES FOR MEDICINAL PRODUCTS FOR HUMAN USE ONLY PROPOSALS FOR APRIL 2002
TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP
DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any
Summary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS (CVMP)
European Medicines Agency Veterinary Medicines and Inspections London, 15 April 2005 EMEA/CVMP/134/02 Rev 1 CPMP/QWP/227/02 Rev 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) COMMITTEE FOR VETERINARY
2 Human medicines: scope of regulation
2 Human medicines: scope of regulation Karen Pitchford Consolidation of Medicines Legislation (2012) Until August 2012, UK medicines legislation comprised the Medicines Act 1968 (the 1968 Act), around
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
Guideline on dossier requirements for Type IA and IB notifications
Guideline on dossier requirements for Type IA and IB notifications In accordance with Regulation (EC) No 726/2004 and Directives 2001/83/EC and 2001/82/EC, a common approach to the procedures for variations
WHO Expert Committee on Specifications for Pharmaceutical Preparations. How does it work?
1 WHO Expert Committee on Specifications for Pharmaceutical Preparations How does it work? Sabine Kopp, PhD Quality Assurance and Safety: Medicines Department of Medicines Policy and Standards Main points
Advertising of medicines: Guidance for providers offering medicinal treatment services
Appendix 6 Advertising of medicines: Guidance for providers offering medicinal treatment services 1. Purpose This guidance has been developed by the Medicines and Healthcare products Regulatory Agency
How To Understand The Paediatric Regulation
Paediatric Use Marketing Authorisation (PUMA) from a National Competent Authority Point of View DGRA Annual Congress 2006 Bonn, 10. May 2006 Dr. Susanne Keitel Content PUMA The Future Background Legislative
Improving international and European healthcare standardization to meet global safety, regulatory and market needs
Improving international and European healthcare standardization to meet global safety, regulatory and market needs A discussion paper from EUCOMED Executive Summary This paper has been produced in order
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au
Proposals for the reform of the regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients
Proposals for the reform of the regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients Summary of responses to consultation document MLX299 January
The Quality System for Drugs in Germany
The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute
UK Implementation of the EU Clinical Trial Directive 2001/20/EC:
UK Implementation of the EU Clinical Trial Directive 2001/20/EC: GCP Aspects. Dr. Colin Wilsher, FRQA. BARQA GCP Committee Chairman; & Pfizer Worldwide Development Quality Assurance. GIQAR, Roma, October
Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human Application
Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human AUT-G0102-1 3 JANUARY 2013 This guide does not purport to be an interpretation of law and/or regulations
Safeguarding public health The Regulation of Software as a Medical Device
Safeguarding public health The Regulation of Software as a Medical Device Dr Head of New and Emerging Technologies Medicines and Healthcare Products Regulatory Agency (MHRA) Crown Copyright 2013 About
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q4B ANNEX 12
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
Official Journal of the European Union. (Acts whose publication is obligatory)
27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending
SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT
SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption
Guide to Fees for Veterinary Products
Guide to Fees for Veterinary Products FIN-G0003-14 04 FEBRUARY 2016 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS ABBREVIATIONS
GMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
Work plan for GMP/GDP Inspectors Working Group for 2016
21 December 2015 EMA/INS/GMP/738756/2015 Compliance and Inspection Work plan for GMP/GDP Inspectors Working Group for 2016 Chairperson: Status David Cockburn January 2016 1. Meetings scheduled for 2016
BEST PRACTICE GUIDE for Handling of Periodic Safety Update Reports
EMEA/CMDv/408477/2007 12 March 2009 BEST PRACTICE GUIDE for Handling of Periodic Safety Update Reports Edition number : 00 Edition date: 12 March 2009 Implementation date : 27 March 2009 CMD(v) Secretariat:
EDQM Certificates of Suitability: Cooperation Among Inspectorates in Europe And Beyond
EDQM Certificates of Suitability: Cooperation Among Inspectorates in Europe And Beyond 14 th International Conference of Drug Regulatory Authorities Pre-ICDRA Meeting Dr Susanne Keitel European Directorate
EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON TABLET FRIABILITY GENERAL CHAPTER Q4B ANNEX 9(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
Annex 6. Guidance on variations to a prequalified product dossier. Preface
Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi
Wanted: strong leadership that makes a real difference...
Wanted: strong leadership that makes a real difference... Clinical Director - Dental Service Full Time 37.5 hours per week Salary Range 70,899-77,248 per annum Further benefits plus relocation assistance
Clinical trials regulation
Clinical trials regulation The Proposal for a Regulation of the European Parliament and of the Council on Clinical Trials on Medicinal Products for Human Use and Repealing Directive 2001/20/EC an update
Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues (revision 1)
22 May 2014 EMA/CHMP/BWP/247713/2012 Committee for Medicinal Products for Human Use (CHMP) Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance:
The International Pharmacopoeia
WHO Drug Information Vol. 27, No. 2, 2013 The International Pharmacopoeia International Meeting of World Pharmacopoeias A pharmacopoeia is a legally binding collection of standards and quality specifications
SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS
SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS June 2006 1 INTRODUCTION Public health concerns demand that the manufacture of pharmaceutical products and their subsequent handling
2014 Annual Report on Inspections of Establishments
2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 15.7.2015 COM(2015) 345 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Review of Directive 2010/30/EU of the European Parliament and of the Council
Medicines and Healthcare Products Regulatory Agency Business Plan 2014-15
Medicines and Healthcare Products Regulatory Agency Business Plan 2014-15 1 Contents 1. Introduction 2. Financial context 3. Key strategic activities for 2014-15: - Vision and scope of our work - Bringing
New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)
Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division
QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 002-3 25 September 2007 RECOMMENDATION ON QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES PIC/S September
The Association for Clinical Biochemistry & Laboratory Medicine Strategic Plan
The Association for Clinical Biochemistry & Laboratory Medicine Strategic Plan Background The ACB has been in existence for 60 years. During that time, laboratory medicine has changed in a way that must
Legal and governance framework
Annex A Legal and governance framework This annex is a brief guide to the legal and governance framework relevant to research in the UK. It is not intended to be a comprehensive statement of the law or
USP CONVENTION MEMBERS BY WORLD REGION
USP CONVENTION MEMBERS BY WORLD REGION April 1, 2015 The 459 organizations listed below are Voting Organizational Members of the U.S. Pharmacopeial Convention (USP). WORLD (8) International Council of
PHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTS Brian R Matthews PDA Bethesda, MD, USA DHI Publishing, LLC River Grove, IL, USA 10 9 8 7 6 5 4 3 2 1 ISBN: x-xxxxxx-xx-x Copyright 2005 Brian R Matthews. All rights reserved.
ONLINE PUBLIC ENGAGEMENT ON PHARMACY BILL
ONLINE PUBLIC ENGAGEMENT ON PHARMACY BILL Honourable Tun / Tan Sri / Dato 'Sri / Datuk / Dato' / Datin / ladies and gentlemen Assalamualaikum and Salam 1Malaysia, Firstly, I wish to take this opportunity
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS
European Medicines Agency Evaluation of Medicines for Human Use CHMP/437/04 London, 30 October 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS
Regulatory Reform: Are we heading in the right direction?
Regulatory Reform: Are we heading in the right direction? Trisha Garrett, Assistant Secretary, Complementary and OTC Medicines Branch 11 November 2015 Where are we going? 2 Update TGA Update 1. TGA restructure
Updated on 01-12-2012
Updated on 01-12-2012 Welcome to readers of Global Research Online, I, Editor in-chief, collected and presented here some useful websites with a view to support and encourage the individuals who engaged
Use of medicines outside of their UK marketing authorisation in pain management and palliative medicine
The British Pain Society Use of medicines outside of their UK marketing authorisation in pain management and palliative medicine This is a consensus document prepared on behalf of the British Pain Society
Draft guidance for registered pharmacies preparing unlicensed medicines
Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies
Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials
Nuclear Technology Management Professional Development Programme
Nuclear Technology Management Professional Development Programme Developing the next generation of technical leaders for the nuclear industry www.manchester.ac.uk/nuclear-pdp Nuclear Technology Management
Department for Transport Consultation: Renewable Transport Fuel Obligation Draft Post Implementation Review. February 2014
Department for Transport Consultation: Renewable Transport Fuel Obligation Draft Post Implementation Review February 2014 The below sections are extracted from a response form submitted to the Department
HSE: Frequently Asked Questions
HSE: Frequently Asked Questions Q1 - What is GHS? A GHS refers to the United Nations (UN) Globally Harmonised System of Classification and Labelling of Chemicals. The UN published GHS in its publication
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing
Minnesota Board of Nursing Nursing Practice Committee. Proposed Changes to the Minnesota Nurse Practice Act
Minnesota Board of Nursing Nursing Practice Committee Proposed Changes to the Minnesota Nurse Practice Act The Minnesota Nurse Practice Act is the law that includes definitions of professional and practical
Job Description. Industry business analyst. Salary Band: Purpose of Job
Job Description Job Title: Industry business analyst Division/Company: Industry Policy/Payments UK Reporting To: Director of Industry Policy Salary and: C Purpose of Job To provide thought leadership and
Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
Knowledge Management policy for Health - Service, Education and Research
Knowledge Management policy for Health - Service, Education and Research (Final Draft Document) 1 Knowledge Management policy for Health - Service, Education and Research Department of Health Research
To: Interested Parties. Our reference: MLX 310 Date: 2 August 2004. Dear Sir/Madam
To: Interested Parties 020 7084 2642 020 7084 2121 anne.thyer@mhra.gsi.gov.uk Our reference: MLX 310 Date: 2 August 2004 Dear Sir/Madam PROPOSALS TO ENABLE THE USE OF ELECTRONIC SIGNATURES ON PRESCRIPTIONS
Manchester Pharmacy School. www.manchester.ac.uk/pharmacy
Manchester Pharmacy School Postgraduate study from Continuous Professional Development (CPD), Certificate, Diploma to Masters (MSc) with flexible, modular learning. The University of Manchester has a proud
The European regulatory system for medicines and the European Medicines Agency
The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union An agency of the European Union This booklet is intended
Pursuant to the authority vested in the Commissioner of Health by Article 33 of the
Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health
THE USE OF DRUGS BEYOND (OFF-LABEL) AND WITHOUT (UNLICENSED) MARKETING AUTHORIZATION
THE USE OF DRUGS BEYOND (OFF-LABEL) AND WITHOUT (UNLICENSED) MARKETING AUTHORIZATION The use of drugs for off-label purposes is widespread. Surveys suggest that up to 1/4 of all prescriptions in palliative
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Page 1 of 17 TABLE OF CONTENTS INTRODUCTION 4 EXECUTIVE SUMMARY 4 PUBLIC HEALTH BENEFITS 5 Good clinical practice 5 Good manufacturing
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
List of Contents Section 10, Nuclear Safety and Radiation Protection Legislation Page
List of Contents Section 10, Nuclear Safety and Radiation Protection Legislation Page Overview 1 The Radiation Protection (Medical Exposures) Directive 11 The Public Information (Radiological Emergency)
Review of Quality Assurance: Terms of Reference. Background
Review of Quality Assurance: Terms of Reference Background 1. The Quality Improvement Framework (QIF) consolidates previous work by the GMC on the quality assurance of basic medical education (QABME) and
2013 HOUSE OF DELEGATES ACTIONS GOVERNMENTAL AFFAIRS AND LEGAL MATTERS (B)
2013 HOUSE OF DELEGATES ACTIONS GOVERNMENTAL AFFAIRS AND LEGAL MATTERS (B) 100 Certificate of Need for Ambulatory Surgery Centers Owned by Physicians RESOLVED, that the Medical Society of the State of
HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER
HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER DISCUSSION IN THE HMPWG 2003-2005 RELEASE FOR CONSULTATION December 2005 DEADLINE
GUIDELINES ON COMPLIANCE WITH AND ENFORCEMENT OF MULTILATERAL ENVIRONMENTAL AGREEMENTS
GUIDELINES ON COMPLIANCE WITH AND ENFORCEMENT OF MULTILATERAL ENVIRONMENTAL AGREEMENTS 1. In its decision 21/27, dated 9 February 2001, the Governing Council of the United Nations Environment Programme
Roadmap to a Sustainable Pan-European Certification of EHR Systems A deliverable of the European project EHR-Q TN
Roadmap to a Sustainable Pan-European Certification of EHR Systems A deliverable of the European project EHR-Q TN François Wisniewski CRP Henri Tudor SANTEC, Luxembourg Regional Conference: EHR Systems
Enhancing of Regulatory Control in Georgia Main Trends and Current Developments
Enhancing of Regulatory Control in Georgia Main Trends and Current Developments GEORGIA Department of Nuclear and Radiation Safety Ministry of Energy 11.12.2012 J. Mamasakhlisi 1 Regulatory control over
A competency framework for all prescribers updated draft for consultation
A competency framework for all prescribers updated draft for consultation Consultation closes 15 April 2016 Contents 1 Introduction... 3 2 Uses of the framework... 4 3 Scope of the competency framework...
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (11) 204 3R HANDLING AND USE OF REFERENCE STANDARDS IN THE OMCL NETWORK Full document title and reference Document type Legislative
Medicines and Healthcare products Regulatory Agency
Medicines and Healthcare products Regulatory Agency 11 April 2016 Update on progress with the Joint Patient Safety and Vigilance Strategy Purpose: This paper provides the Board with an update on the Joint
training programme in pharmaceutical medicine Regulatory affairs
training programme in pharmaceutical medicine Regulatory affairs INFARMED, Lisbon 19-21 january 2012 Regulatory affairs 19 21 january 2012 LocaL: INFARMED, Lisbon curricular unit Leader: Hélder Mota Filipe,
OLD MUTUAL S RESPONSIBLE INVESTMENT POLICY
OLD MUTUAL S RESPONSIBLE INVESTMENT POLICY >> CONTENTS 1 OLD MUTUAL S RESPONSIBLE INVESTMENT POLICY 01 Our understanding of responsible investment Responsible investment compared to investment in sustainability
TGA key performance indicators and reporting measures
TGA key indicators and reporting measures Regulator Performance Framework Version 1.0, May 2015 About the Therapeutic Goods Administration (TGA) The Therapeutic Goods Administration (TGA) is part of the
Regulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
GUIDELINES ON MEDICAL DEVICES. IVD GUIDANCES : Borderline issues A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology MEDDEV. 2.14/1 rev. 1 January
Food supplements. Summary information on legislation relating to the sale of food supplements
Food supplements Summary information on legislation relating to the sale of food supplements 1 This guidance applies to the whole of the UK and was prepared by the Department of Health in association with
Consultation on Regulation of Independent Healthcare in Scotland. Consultation Report
Consultation on Regulation of Independent Healthcare in Scotland Consultation Report Consultation on Regulation of Independent Healthcare in Scotland Consultation Report The Scottish Government, Edinburgh
Standards and accreditation. Tools for delivering better regulation
Standards and accreditation Tools for delivering better regulation Introduction Standards and accreditation are marketbased tools that can be used by Government policy makers to deliver better regulation.
Presented by Dr. K M Choy, Consultant (PPP)
Electronic Health Record Engagement Initiative (EEI) Invitation Exercise Presented by Dr. K M Choy, Consultant (PPP) ehr Engagement Initiative (EEI) EEI Invitation Document Private Sector Stakeholders
VOLUME 2A Procedures for marketing authorisation CHAPTER 1 MARKETING AUTHORISATION. November 2005
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, ENTR/F2/BL D(2002) NOTICE TO APPLICANTS Revision 3 VOLUME 2A Procedures for marketing authorisation CHAPTER 1
Does my project require review by a Research Ethics Committee?
National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project
The Regulation of Medical Devices in the UK
The Regulation of Medical Devices in the UK 1. What are the main requirements for a medical device to enter into the market and how are they regulated? Are there any licensing, marketing authorisation,
Medical Devices. Notified Bodies and the CE certification Process for Medical Devices. European Surgical Robotics Demonstration Day
Medical Devices Notified Bodies and the CE certification Process for Medical Devices European Surgical Robotics Demonstration Day 27 th March 2014, Leuven, Belgium 1 Bart Mersseman Product Manager Medical
Information Governance and Management Standards for the Health Identifiers Operator in Ireland
Information Governance and Management Standards for the Health Identifiers Operator in Ireland 30 July 2015 About the The (the Authority or HIQA) is the independent Authority established to drive high